alta-icon logo-altasciences

EN - Main navigation

  • Acceleration Platform
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
Français
  • Home
  • Current: Our Solutions

Our Solutions

Altasciences reimagines the path to clinical proof-of-concept. It is our mission to empower life science innovators to make faster, more confident decisions about their most promising therapies.

You have the flexibility to partner with Altasciences for a standalone service, a combination of services, or an entire program. No matter what you choose, our operations are intentionally structured to be faster by design, with operational efficiency that helps you reach critical inflection points sooner without compromising scientific excellence.

Click below to explore each of our solution offerings.

Our Solutions

  • Preclinical Studies - Safety assessments for both small and large molecules

    ALTASCIENCES Nonclinical Services

    Safety assessments for both small and large molecules

  • Clinical Services - Clinical pharmacology trials from first-in-human to end of Phase II

    ALTASCIENCES Clinical Services

    Clinical pharmacology trials from first-in-human to end of Phase II

  • Manufacturing and Analytical Services

    ALTASCIENCES Manufacturing and Analytical Services

    From formulation development, Phase I through commercial manufacturing, and ICH stability testing

  • Bioanalysis & Research Services

    ALTASCIENCES Bioanalytical Services

    As part of our full service offering or as standalone solutions

  • CRO services

    ALTASCIENCES CRO Services

    Full array of complementary services needed to complete your projects.


Altasciences Acceleration Platform

To get the biggest time savings, the Altasciences Acceleration Platform bridges the gaps between nonclinical, clinical, bioanalysis, and manufacturing stages. It aligns scientific, regulatory, and operational functions within a single framework, reducing your drug development timelines by up to 40%.

Click below to discover if the Acceleration Platform is the right fit for you.

  • Acceleration Platform Thumbnail

    Acceleration Platform

    Reach clinical proof-of-concept in as little as 18 months, with integrated nonclinical, clinical, bioanalysis, and manufacturing services.

More Ways to Explore Our Solutions

Uncover our capabilities by therapeutic area, molecule type, or modality.

  • Small Molecule Therapeutic Areas
  • Large Molecule Development Programs
  • Cell and Gene Therapy Development Cell and Gene Therapy Development
  • Small Molecule Small Molecule Solutions
  • Large Molecule Large Molecule Solutions

... an important partner in our development efforts and we recommend them for any ligand-binding requirements.

Bryan Tayefeh, Assistant Director, Alliance Management Ionis Pharmaceuticals, Inc.

I ... commend Altasciences on their scientific knowledge, efficient and timely processes, and excellent customer service.

R. Brent Miller, Ph.D., PMP Vice President, Product & Portfolio Development NeuroTrauma Sciences, LLC

It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions.

Marie-Francoise Temam, Associate Director, Clinical Operations, Idenix, a wholly-owned subsidiary of Merck & Company

I recommend this site because of the expertise and quality of trials performed.

Okba Haj-Ali Saflo, Clinical Research Scientist, Chemo Group

... the communication between our teams was optimal, from the first protocol draft to the delivery of final report.

Maxime Ranger, President and CEO, gIcare pharma inc

We have been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants.

Hélène Dulude, B.Pharm., Ph.D., Director, Clinical Development, Locemia Solutions ULC

Sign up for exclusive content

Join our list of 30,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Media Kit
    • Resource Center

      • The Altascientist
      • Webinars
      • Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Dose Range Finding​
      • Preclinical Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Cell and Gene Therapy
      • Pivotal Toxicology
      • Safety Pharmacology
      • Immunotoxicology/Immunology
      • Clinical
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • CNS/Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2026 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Captcha is required.